Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
CALL
United States Brent Oil Fund
BNO
$784M
| $25.2M | 0.01% |
769,300
+591,300
| +332% | +$19M |
|
1552
CALL
KB Home
KBH
$3.43B
| $25.2M | 0.01% |
884,900
+507,100
| +134% | +$16.2M |
|
1553
PUT
PG&E
PCG
$39.2B
| $25.2M | 0.01% |
2,523,300
+1,749,700
| +226% | +$20.6M |
|
1554
Verizon
VZ
$201B
| $25.2M | 0.01% |
496,154
-2,494,091
| -83% | -$126M |
|
|
GRMN
1555
CALL
Garmin
GRMN
$60.1B
| $25.2M | 0.01% |
256,100
-45,800
| -15% | -$4.82M |
|
|
1556
KB Home
KBH
$3.43B
| $25.1M | 0.01% |
882,300
+655,915
| +290% | +$20.9M |
|
1557
Ventas
VTR
$46.8B
| $25.1M | 0.01% |
488,134
-218,610
| -31% | -$12.2M |
|
|
HR
1558
DELISTED
Healthcare Realty Trust Incorporated
HR
| $25M | 0.01% |
920,252
-275,896
| -23% | -$7.71M |
|
|
LFG
1559
DELISTED
Archaea Energy Inc.
LFG
| $25M | 0.01% |
1,610,826
+470,353
| +41% | +$9.54M |
|
|
CLAA
1560
DELISTED
Colonnade Acquisition Corp. II
CLAA
| $25M | 0.01% |
2,550,047
+17
| +0% | +$166 |
|
|
NEE.PRO
1561
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
| $25M | 0.01% |
442,783
| – | – |
|
|
JBIO
1562
Jade Biosciences
JBIO
$1.58B
| $24.9M | 0.01% |
45,486
-39
| -0.1% | -$18.6K |
|
|
CHAA
1563
DELISTED
Catcha Investment Corp
CHAA
| $24.9M | 0.01% |
2,533,650
+2,304
| +0.1% | +$22.6K |
|
1564
Oracle
ORCL
$430B
| $24.9M | 0.01% |
355,846
-2,508,224
| -88% | -$184M |
|
1565
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $24.8M | 0.01% |
933,785
-43,912
| -4% | -$1.31M |
|
1566
Pinduoduo
PDD
$120B
| $24.8M | 0.01% |
401,809
-196,558
| -33% | -$9.21M |
|
1567
CALL
Royal Gold
RGLD
$19.6B
| $24.8M | 0.01% |
232,300
+33,100
| +17% | +$4.09M |
|
|
BRSL
1568
Brightstar Lottery PLC
BRSL
$2.17B
| $24.8M | 0.01% |
1,336,277
+1,105,754
| +480% | +$23.6M |
|
1569
PUT
J.M. Smucker
SJM
$12.9B
| $24.8M | 0.01% |
193,500
+108,100
| +127% | +$14.4M |
|
|
WRK
1570
DELISTED
WestRock Company
WRK
| $24.7M | 0.01% |
620,757
-188,387
| -23% | -$8.86M |
|
1571
Capital One
COF
$139B
| $24.7M | 0.01% |
237,344
+208,795
| +731% | +$25.5M |
|
|
MTVC
1572
DELISTED
Motive Capital Corp II
MTVC
| $24.7M | 0.01% |
2,500,000
-175,692
| -7% | -$1.74M |
|
|
CMRC
1573
Commerce.com Inc Series 1
CMRC
$183M
| $24.7M | 0.01% |
1,524,875
+1,480,416
| +3,330% | +$27.1M |
|
1574
Atkore
ATKR
$3.17B
| $24.7M | 0.01% |
297,463
+210,285
| +241% | +$20.9M |
|
1575
H&R Block
HRB
$6.88B
| $24.7M | 0.01% |
698,824
+373,670
| +115% | +$11.5M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.